JUAN WOOD BUILDING MATERIALS CO., LTD.
Update：2024/12/24
Industries
Main Industry
Community and Lifestyle
Main Product/Service
One-stop service including design, construction, and operation maintenance of mini intelligent cell therapy product factories
A one-stop solution that covers the design, construction, operation, maintenance, and technical services for cell production in a miniature intelligent cell preparation plant meets customer needs for immune cells, stem cells, and exosomes.
The highly integrated modular design and exclusive efficient processes allow for economically beneficial cell production in small spaces, even within conventional hospital structures.
YJ Biotech is actively collaborating with medical institutions domestically and internationally to create a decentralized clinical cell manufacturing model. This approach aims to address end-to-end logistics challenges in cell product delivery, providing medical institutions' clients with an enhanced cellular therapy experience.
A one-stop solution that covers the design, construction, operation, maintenance, and technical services for cell production in a miniature intelligent cell preparation plant meets customer needs for immune cells, stem cells, and exosomes.
The highly integrated modular design and exclusive efficient processes allow for economically beneficial cell production in small spaces, even within conventional hospital structures.
YJ Biotech is actively collaborating with medical institutions domestically and internationally to create a decentralized clinical cell manufacturing model. This approach aims to address end-to-end logistics challenges in cell product delivery, providing medical institutions' clients with an enhanced cellular therapy experience.
Founded Year
2016
Unified Business No.
45079179
Status
Active
Number of Employees
15
Total Paid-in
Capital
1,000,000 (NT$)
Location of Company
Taiwan
, Changhua County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Established in March 2020, YJ Biotech Co., Ltd. is headquartered in Linkou District, New Taipei City, Taiwan. We adhere to the core values of pragmatism, professionalism, and innovative excellence. Leveraging Taiwan's top-notch medical and technological capabilities, we are at the forefront of advanced cell manufacturing technologies.
YJ Biotech possesses three key technologies and more than 12 exclusive patents. It is also the first in Taiwan to follow the GMP standard to establish a cell preparation site (CPU) using "Pharmaceutical Isolation Equipment (YJ-Isolator)", which has been recognized and verified by the GTP under the Regulations of Special Medical Techniques. Our PIC/S GMP-in-Design Cell Manufacturing Platform continually breaks through the technological boundaries of cell manufacturing. It provides an all-in-one service to meet the needs of various cells and their derivatives, such as exosomes, for treating multiple diseases and cancers.
YJ Biotech is committed to expanding its presence in the international market, employing a dual-engine development strategy. We actively collaborate with domestic and international medical institutions, research units, and industry supply chains to promote decentralized cell manufacturing models. Additionally, we accelerate the clinical trials of new drug formulations, aligning Taiwan's cell manufacturing industry with international standards.
YJ Biotech possesses three key technologies and more than 12 exclusive patents. It is also the first in Taiwan to follow the GMP standard to establish a cell preparation site (CPU) using "Pharmaceutical Isolation Equipment (YJ-Isolator)", which has been recognized and verified by the GTP under the Regulations of Special Medical Techniques. Our PIC/S GMP-in-Design Cell Manufacturing Platform continually breaks through the technological boundaries of cell manufacturing. It provides an all-in-one service to meet the needs of various cells and their derivatives, such as exosomes, for treating multiple diseases and cancers.
YJ Biotech is committed to expanding its presence in the international market, employing a dual-engine development strategy. We actively collaborate with domestic and international medical institutions, research units, and industry supply chains to promote decentralized cell manufacturing models. Additionally, we accelerate the clinical trials of new drug formulations, aligning Taiwan's cell manufacturing industry with international standards.
